Outcome Measure | Number of trials included | Follow-up time point range | Odds Ratio | 95% CI | I2 | P Value |
Patient Hospitalisation | 6 | 12–18 months | 0.89 | 0.64 to 1.25 | 0% | 0.50 |
Patient Institutionalisation | 9 | 10–12 months | 0.60 | 0.32 to 1.11 | 48% | 0.10 |
Patient Mortality | 9 | 6–12 months | 0.97 | 0.81 to 1.16 | 0% | 0.73 |
Outcome Measure | Number of trials included | Â | Standardised Mean Difference | 95% CI | I2 | P Value |
Patient Quality of Life | 3 | 12 months | 0.09 | −0.09 to 0.27 | 0% | 0.35 |
Patient Cognition | 4 | 12 months | −0.09 | −0.29 to 0.11 | 0% | 0.40 |
Patient Function | 3 | 6 months | −0.08 | −0.30 to 0.14 | 0% | 0.46 |
Caregiver Burden | 5 | 6–18 months | −0.54 | −1.01 to −0.07 | 92% | 0.02 |
Caregiver Mood | 6 | 6–18 months | −0.04 | −0.10 to 0.01 | 0% | 0.10 |
Caregiver Quality of Life | 4 | 9–12 months | 0.45 | −0.03 to 0.94 | 89% | 0.07 |
Social Support | 3 | 12 months | 0.38 | −0.08 to 0.84 | 81% | 0.10 |
Outcome Measure | Number of trials included | Â | Mean Difference | 95% CI | I2 | P Value |
Patient Behaviour | 4 | 12 months | −9.52 | −18.05 to −1.00 | 88% | 0.03 |
Patient Depression | 3 | 9–12 months | 0.60 | −1.08 to 2.27 | 66% | 0.48 |